CStone Pharmaceuticals Investor Relations Material
Latest events
H1 2023
CStone Pharmaceuticals
H1 2025
14 Aug, 2025
H2 2024
27 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from CStone Pharmaceuticals
Access all reports
CStone Pharmaceuticals is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative cancer and autoimmune disease treatments. The company specializes in precision medicine and immuno-oncology therapies, leveraging a pipeline of monoclonal antibodies and targeted small molecules. CStone conducts clinical research and collaborates with global pharmaceutical partners to advance its drug candidates. The company is headquartered in Suzhou, China, and its shares are listed on the HKEX.
Key slides for CStone Pharmaceuticals
Investor Update
CStone Pharmaceuticals
H1 2025
CStone Pharmaceuticals
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
2616
Country
🇭🇰 Hong Kong